Xylem Raises FY2023 Adj EPS Guidance from $3.50-$3.70 to $3.71-$3.73 vs $3.62 Est; Raises FY2023 Sales Guidance from $7.20B to $7.30B vs $7.20B Est
Portfolio Pulse from Benzinga Newsdesk
Xylem has raised its FY2023 adjusted EPS guidance from $3.50-$3.70 to $3.71-$3.73, beating the estimated $3.62. The company also increased its FY2023 sales guidance from $7.20B to $7.30B, again surpassing the estimated $7.20B. The full-year 2023 revenue is now expected to be approximately $7.3 billion, up about 32% on a reported basis and about 11% on an organic basis. The adjusted EBITDA margin for FY2023 is expected to be around 19%, up from the previous 18%.
October 31, 2023 | 10:58 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Xylem has raised its FY2023 EPS and sales guidance, both surpassing estimates. This positive financial outlook could potentially boost the company's stock in the short term.
Xylem's raised guidance for FY2023 indicates a strong financial performance, which is a positive signal to investors. This could lead to increased demand for the company's stock, potentially driving its price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100